Article
Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer.
International journal of clinical oncology - 1 Dec 2013
Nakanishi Ryota, Harada Jun, Tuul Munkhbold, Zhao Yan, Ando Koji, Saeki Hiroshi, Oki Eiji, Ohga Takefumi, Kitao Hiroyuki, Kakeji Yoshihiro, Maehara Yoshihiko
Abstract excerpt
BACKGROUND: Mutations of the KRAS or BRAF genes are now recognized as prognostic markers for colorectal cancer (CRC). They are also important predictive markers for resistance to the monoclonal antibodies that target the epidermal growth factor receptor. METHODS: In this retrospective study, KRAS and BRAF mutations were analyzed using a direct sequence method in 254 Japanese CRC patients, and the associations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
